Hangzhou Dinova EP Technology Co., Ltd
To evaluate the safety and effectiveness of the SnowyTM PFO closure system in plugging patent foramen ovale
Patent Foramen Ovale
SnowyTM PFO closure system
Cardi-o-fix PFO occluder
Not Applicable
A prospective, multicenter, randomized controlled clinical trial is conducted to evaluate the safety and effectiveness of PFO closure system produced by Hangzhou Dinova EP Technology Co., Ltd.., Ltd. in closing patent foramen ovale (PFO). 242 patients are expected to be selected. They are randomly divided into the PFO closure system treatment group (121 cases) and the Chinese medicine Shengjie Cardi-o-fix PFO occluder treatment group (121 cases) according to 1:1. All patients will be followed up to 7 days after operation or before discharge, 1 month, 3 month, 6 month, 1 year, 2 year, 3 year, 4 year and 5 year.}}
Study Type : | Interventional |
Estimated Enrollment : | 242 participants |
Masking : | None (Open Label) |
Primary Purpose : | Prevention |
Official Title : | A Prospective, Multicenter, Randomized Controlled Clinical Study on the Safety and Effectiveness of the SnowyTM PFO Closure System in Plugging Patent Foramen Ovale |
Actual Study Start Date : | October 20, 2023 |
Estimated Primary Completion Date : | December 20, 2023 |
Estimated Study Completion Date : | December 20, 2027 |
Arm | Intervention/treatment |
---|---|
Experimental: treatment group Percutaneously occlusion of PFO with SnowyTM PFO closure system |
Device: SnowyTM PFO closure system |
Experimental: control group Percutaneously occlusion of PFO with Cardi-o-fix PFO occluder |
Device: Cardi-o-fix PFO occluder |
Ages Eligible for Study: | 18 Years to 65 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210029